Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Clinical and biological correlates of blast-transformed chronic myelomonocytic leukemia (CMML): A multicenter study of 493 paired cases at chronic phase and at blast transformation

Blood (2025) 146 (Supplement 1): 2081.

https://doi.org/10.1182/blood-2025-2081

Published: 2025

Journal Articles

Does stringent cytoreduction improve survival in myeloproliferative chronic myelomonocytic leukemia? a correlative study on the dacota trial.

Blood (2025) 146 (Supplement 1): 791.

https://doi.org/10.1182/blood-2025-791

Published: 2025

Journal Articles

Cytokine-like protein 1–induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML

Blood (2021) 137 (24): 3390–3402.

https://doi.org/10.1182/blood.2020008729

Published: 2021

Includes: Supplemental data

Journal Articles

Decitabine Versus Hydroxyurea for Advanced Proliferative CMML: Results of the Emsco Randomized Phase 3 Dacota Trial

Blood (2020) 136 (Supplement 1): 53–54.

https://doi.org/10.1182/blood-2020-138680

Published: 2020

Journal Articles

The Absolute Count of Circulating, Classical, CD14 ++ /CD16 - Monocytes Is a Poor Prognosis Marker in Chronic Myelomonocytic Leukemia (CMML)

Matthieu Jestin, Sihem Tarfi, PharmD, Bouchra Badaoui, PharmD, Nicolas Freynet, PharmD, Ivan Sloma, PharmD,PhD, Margot Morabito, Sébastien Maury, MD PhD, Pierre Fenaux, MD PhD, Eric Solary, MD PhD, Dorothée Selimoglu-Buet, PhD, Orianne Wagner Ballon, MD PhD

Blood (2019) 134 (Supplement_1): 4242.

https://doi.org/10.1182/blood-2019-121794

Published: 2019

Journal Articles

Disappearance of Slan-Positive Non-Classical Monocytes As a New Parameter for the Diagnosis of Chronic Myelomonocytic Leukemia with Associated Inflammatory State

Sihem Tarfi, PharmD, Bouchra Badaoui, PharmD, Nicolas Freynet, PharmD, Margot Morabito, Jeffie Lafosse, Andrea Toma, MD PhD, Pierre Fenaux, MD PhD, Eric Solary, MD PhD, Dorothée Selimoglu-Buet, PhD, Orianne Wagner Ballon, MD PhD

Blood (2018) 132 (Supplement 1): 4376.

https://doi.org/10.1182/blood-2018-99-116451

Published: 2018

Journal Articles

Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML

Dorothée Selimoglu-Buet, Bouchra Badaoui, Emmanuel Benayoun, Andréa Toma, Pierre Fenaux, Bruno Quesnel, Gabriel Etienne, Thorsten Braun, Nassera Abermil, Margot Morabito, Nathalie Droin, Eric Solary, Orianne Wagner-Ballon

Blood (2017) 130 (6): 832–835.

https://doi.org/10.1182/blood-2017-04-779579

Published: 2017

Journal Articles

MIR150 Is Involved in the Monocyte Subset Differentiation and Its Down-Regulation Leads to Classical Monocyte Accumulation in Chronic Myelomonocytic Leukemia

Dorothee Selimoglu-Buet, PhD, Julie Riviere, PhD, Margot Morabito, Catherine Lacout, Aurelie Chauveau, MD, Camille Debord, Raphaël Itzykson, MD PhD, Pierre Fenaux, MD PhD, Nathalie M. Droin, PhD, Éric Solary, MD PhD

Blood (2016) 128 (22): 1133.

https://doi.org/10.1182/blood.V128.22.1133.1133

Published: 2016

Journal Articles

Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia

Blood (2015) 125 (23): 3618–3626.

https://doi.org/10.1182/blood-2015-01-620781

Published: 2015

Includes: Supplemental data

Journal Articles

Clonal architecture of chronic myelomonocytic leukemias

Raphaël Itzykson, Olivier Kosmider, Aline Renneville, Margot Morabito, Claude Preudhomme, Céline Berthon, Lionel Adès, Pierre Fenaux, Uwe Platzbecker, Olivier Gagey, Philippe Rameau, Guillaume Meurice, Cédric Oréar, François Delhommeau, Olivier A. Bernard, Michaela Fontenay, William Vainchenker, Nathalie Droin, Eric Solary

Blood (2013) 121 (12): 2186–2198.

https://doi.org/10.1182/blood-2012-06-440347

Published: 2013

Includes: Supplemental data

Journal Articles

Comprehensive Genetic Screening of Chronic Myelomonocytic Leukemias (CMML)

Raphael Itzykson, Olivier Kosmider, MD, PhD, Aline Renneville, Margot Morabito, Céline Berthon, MD, PhD, Lionel Ades, MD, PhD, Pierre Fenaux, MD, PhD, Odile Beyne-Rauzy, MD, PhD, Thorsten Braun, Francois Dreyfus, Nicholas C.P. Cross, PhD, Claude Preudhomme, Olivier A. Bernard, PhD, Michaela Fontenay, MD, PhD, William Vainchenker, MD, PhD, Nathalie Droin, Ph.D, Eric Solary

Blood (2012) 120 (21): 3811.

https://doi.org/10.1182/blood.V120.21.3811.3811

Published: 2012

Journal Articles

Two Distinct Mechanisms Contribute to Granulomonocytic Hyperplasia in Chronic Myelomonocytic Leukemias (CMML)

Raphael Itzykson, Olivier Kosmider, MD, PhD, Aline Renneville, Margot Morabito, Dorothee Buet, Claude Preudhomme, Céline Berthon, MD, PhD, Lionel Ades, MD, PhD, Pierre Fenaux, MD, PhD, Uwe Platzbecker, MD, Olivier Gagey, Philippe Rameau, Francois Delhommeau, PharmD, PHD, Olivier A. Bernard, PhD, Michaela Fontenay, MD, PhD, William Vainchenker, MD, PhD, Nathalie Droin, Ph.D, Eric Solary

Blood (2012) 120 (21): 309.

https://doi.org/10.1182/blood.V120.21.309.309

Published: 2012

Journal Articles

MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations

Iléana Antony-Debré, Dominique Bluteau, Raphael Itzykson, Véronique Baccini, Aline Renneville, Françoise Boehlen, Margot Morabito, Nathalie Droin, Caroline Deswarte, Yunhua Chang, Guy Leverger, Eric Solary, William Vainchenker, Rémi Favier, Hana Raslova

Blood (2012) 120 (13): 2719–2722.

https://doi.org/10.1182/blood-2012-04-422352

Published: 2012

Includes: Supplemental data

Journal Articles

Myeloid-Derived Suppressive Cells Belonging to the Leukemic Clone Account for Immunosuppression In CMML

Nathalie Droin, Raphael Itzykson, Philippe Rameau, Margot Morabito, Thorsten Braun, Fawzia Louache, Yanyan Zhang, Stephane De Botton, Catherine Cordonnier, Bruno Quesnel, Pierre Fenaux, MD, PhD, William Vainchenker, Eric Solary

Blood (2010) 116 (21): 3997.

https://doi.org/10.1182/blood.V116.21.3997.3997

Published: 2010

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Clinical and biological correlates of blast-transformed chronic myelomonocytic leukemia (CMML): A multicenter study of 493 paired cases at chronic phase and at blast transformation

Does stringent cytoreduction improve survival in myeloproliferative chronic myelomonocytic leukemia? a correlative study on the dacota trial.

Cytokine-like protein 1–induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML

Decitabine Versus Hydroxyurea for Advanced Proliferative CMML: Results of the Emsco Randomized Phase 3 Dacota Trial

The Absolute Count of Circulating, Classical, CD14 ++ /CD16 - Monocytes Is a Poor Prognosis Marker in Chronic Myelomonocytic Leukemia (CMML)

Disappearance of Slan-Positive Non-Classical Monocytes As a New Parameter for the Diagnosis of Chronic Myelomonocytic Leukemia with Associated Inflammatory State

Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML

MIR150 Is Involved in the Monocyte Subset Differentiation and Its Down-Regulation Leads to Classical Monocyte Accumulation in Chronic Myelomonocytic Leukemia

Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia

Clonal architecture of chronic myelomonocytic leukemias

Comprehensive Genetic Screening of Chronic Myelomonocytic Leukemias (CMML)

Two Distinct Mechanisms Contribute to Granulomonocytic Hyperplasia in Chronic Myelomonocytic Leukemias (CMML)

MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations

Myeloid-Derived Suppressive Cells Belonging to the Leukemic Clone Account for Immunosuppression In CMML

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only